12/16/2025 | Press release | Distributed by Public on 12/16/2025 16:56
|
FORM 4
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|
|||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) | ||
|
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) |
4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Employee Stock Option (right to buy) | $44.47 | (3) | 03/12/2031 | Common Stock | (4) | 20,000 | D | ||||||||
| Employee Stock Option (right to buy) | $36.62 | (5) | 03/14/2032 | Common Stock | (4) | 46,000 | D | ||||||||
| Employee Stock Option (right to buy) | $50.82 | (6) | 03/14/2033 | Common Stock | (4) | 19,998 | D | ||||||||
| Employee Stock Option (right to buy) | $50.82 | (7) | 03/14/2033 | Common Stock | (4) | 20,000 | D | ||||||||
| Employee Stock Option (right to buy) | $60.30 | (8) | 03/14/2034 | Common Stock | (4) | 18,000 | D | ||||||||
| Employee Stock Option (right to buy) | $55.09 | (9) | 03/14/2035 | Common Stock | (4) | 21,000 | D | ||||||||
| Restricted Stock Units | (10) | (11) | (12) | Common Stock | (4) | 1,680 | D | ||||||||
| Restricted Stock Units | (10) | (13) | (12) | Common Stock | (4) | 7,480 | D | ||||||||
| Restricted Stock Units | (10) | (14) | (12) | Common Stock | (4) | 5,100 | D | ||||||||
| Restricted Stock Units | (10) | (15) | (12) | Common Stock | (4) | 5,400 | D | ||||||||
| Restricted Stock Units | (10) | (16) | (12) | Common Stock | (4) | 7,000 | D | ||||||||
| Reporting Owner Name / Address | Relationships | |||
| Director | 10% Owner | Officer | Other | |
|
Tirre Emelie 1 MONSTER WAY CORONA, CA 92879 |
Chief Commercial Officer | |||
| Paul J. Dechary, attorney-in-fact | 12/16/2025 | |
| **Signature of Reporting Person | Date |
| * | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| (1) | This transaction was executed in multiple trades at prices ranging from $73.29 to $73.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| (2) | This amount reflects the reported transaction and 1,232 additional shares that were inadvertently omitted from the reporting person's most recently filed Form 4 due to an administrative error. |
| (3) | The options are currently vested with respect to 14,000 shares. The remaining options vest on March 12, 2026. |
| (4) | No transaction is being reported at this time. This line is only reporting holdings as of the date hereof. |
| (5) | The options are currently vested with respect to 20,700 shares. The remaining options vest in two installments as follows: 11,500 shares on March 14, 2026 and 13,800 shares on March 14, 2027. |
| (6) | The options are currently vested with respect to 5,000 shares. The remaining options vest in three installments as follows: 4,000 shares on March 14, 2026; 5,000 shares on March 14, 2027 and 6,000 shares on March 14, 2028. |
| (7) | The options are currently vested with respect to 13,332 shares. The remaining options vest on March 14, 2026. |
| (8) | The options are currently vested with respect to 1,800 shares. The remaining options vest in four installments as follows: 2,700 shares on March 14, 2026; 3,600 shares on March 14, 2027; 4,500 shares on March 14, 2028 and 5,400 shares on March 14, 2029. |
| (9) | The options vest in four equal installments on March 14, 2026, March 14, 2027, March 14, 2028 and March 14, 2029. |
| (10) | The restricted stock units were granted under the Monster Beverage Corporation 2020 Omnibus Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock as of the vesting date. |
| (11) | The restricted stock units vest on March 12, 2026. |
| (12) | Not applicable. |
| (13) | The restricted stock units vest in two installments as follows: 3,400 units on March 14, 2026 and 4,080 units on March 14, 2027. |
| (14) | The restricted stock units vest in three installments as follows: 1,360 units on March 14, 2026; 1,700 units on March 14, 2027 and 2,040 units on March 14, 2028. |
| (15) | The restricted stock units vest in four installments as follows: 900 units on March 14, 2026; 1,200 units on March 14, 2027; 1,500 units on March 14, 2028 and 1,800 units on March 14, 2029. |
| (16) | The restricted stock units vest in four equal installments on March 14, 2026, March 14, 2027, March 14, 2028 and March 14, 2029. |